Concepedia

Morton Scheinberg

MS

Statistics

Publications

77

Citations

5.3K

H-Index

32

Active since

1972

Affiliations

Hospital Israelita Albert Einstein(Current)

Universidade de São Paulo

University of Southern California

GlaxoSmithKline (United States)

Associação de Assistência à Criança Deficiente

Morton Scheinberg is an author at Hospital Israelita Albert Einstein specializing in medicine, immunology, and autoimmune disease.

ORCID

Top concepts

Publications per year

1972–2021

77

Publications

77

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

Merrill D. Benson, Márcia Waddington‐Cruz, John L. Berk et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

Nicolino Ruperto, Daniel J. Lovell, Pierre Quartier et al. · The Lancet · 2008 · 543 citations

, , +8

Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus

William Stohl, Falk Hiepe, Kevin Latinis et al. · Arthritis & Rheumatism · 2012 · 408 citations · Full text

Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study

William Stohl, Andreas Schwarting, Masato Okada et al. · Arthritis & Rheumatology · 2017 · 391 citations · Full text

A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study

Richard Furie, G. Léon, Meenu Thomas et al. · Annals of the Rheumatic Diseases · 2014 · 162 citations

1–5 of 77